Evidence map›Paper›PMID 31507421›Full record

ArticleFrontiers in pharmacology2019

Jian Gao, Qiming Wang, Yuwei Huang, Kailin Tang, Xue Yang, Zhiwei Cao

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jian GaoShanghai 10th People's Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China.
Qiming WangShanghai 10th People's Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China.
Yuwei HuangShanghai 10th People's Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China.
Kailin TangShanghai 10th People's Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China.
Xue YangDepartment of Traditional Chinese Medicine, Yangpu Hospital, School of Medicine, TongJi University, Shanghai, China.
Zhiwei CaoShanghai 10th People's Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China.
Tongji University · CNYangpu Hospital of Tongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insomnia is a common and widespread sleeping disorder caused by various risk factors. Though beneficial, conventional treatments of insomnia have significant limitations. As an alternative treatment, Chinese herbal formula Suanzaoren prescription (SZRP), composed of Suanzaoren [seeds of

Indexed as

bioinformaticsinsomnianetwork pharmacologysuanzaoren prescriptionsystematic analysis

Identifiers

PMID31507421
PMCPMC6713715
OpenAlexW2964080412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.